Prolacta Bioscience

Prolacta Bioscience is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta develops clinically proven, high-quality products derived from human milk that are designed to meet the needs of extremely premature infants in the NICU.

Prolacta’s first commercial product, Prolact+ H2MF®, a Human Milk Fortifier (HMF) made exclusively with 100 percent donor breast milk, is now licensed and available in Canada. A 100% human milk diet for premature infants has been shown to result in improved health outcomes and cost savings due to a decrease in the incidence and severity of co-morbidities.